Fulcrum Therapeutics Inc (FULC) returns
Fulcrum Therapeutics returns over 5 years
$1,000 invested in Fulcrum Therapeutics five years ago was worth $167.57 at the close on October 30, 2026, with dividends reinvested: an average return of -30.0% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +0.3% | — | $1,003 | -0.9% |
| 3 months | -0.3% | — | $997.31 | +2.1% |
| Year to date | -67.2% | — | $328.03 | +11.7% |
| 1 year | -56.9% | — | $431.40 | +12.4% |
| 3 years | +10.7% | +3.5% | $1,107 | +88.5% |
| 5 years | -83.2% | -30.0% | $167.57 | +76.0% |
Fulcrum Therapeutics return by calendar year
| Year | FULC | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -67.2% | +11.7% | -78.9% |
| 2025 | +140.6% | +17.7% | +122.9% |
| 2024 | -30.4% | +24.9% | -55.3% |
| 2023 | -7.3% | +26.2% | -33.5% |
| 2022 | -58.8% | -18.2% | -40.7% |
| 2021 | +51.1% | +28.7% | +22.3% |
| 2020 | -29.6% | +18.4% | -48.0% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: FULC financials
No forecast, no recommendation. This page describes Fulcrum Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.